Ajeet Kumar | Hematological Malignancies | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Ajeet Kumar
All India Institute of Medical Sciences Patna, India

Ajeet Kumar
Affiliation All India Institute of Medical Sciences Patna
Country India
Documents 16
Subject Area Hematological Malignancies
Event International Young Scientists Award
ORCID 0000-0002-5411-2783

Ajeet Kumar is affiliated with the All India Institute of Medical Sciences Patna, India, where his research activities focus on hematological malignancies and related areas of clinical and translational medicine. His scholarly work reflects sustained contributions toward understanding blood cancers, improving diagnostic approaches, and supporting evidence-based patient management. Through scientific publications and collaborative research initiatives, he has contributed to advancing knowledge within hematology while promoting high standards of academic integrity and research quality. His professional profile demonstrates continued engagement with scientific communication, interdisciplinary collaboration, and healthcare research, making him a suitable candidate for recognition through the International Young Scientists Award.[1]

Abstract

Ajeet Kumar has established an active academic profile through research focused on hematological malignancies, emphasizing clinical relevance, translational medicine, and scientific collaboration. His publications contribute to the growing body of literature addressing blood disorders and cancer research while encouraging improved healthcare practices. The combination of research productivity, institutional affiliation, and commitment to evidence-based medicine reflects continued professional development and scientific engagement.[2]

Keywords

  • Hematological Malignancies
  • Clinical Research
  • Cancer Biology
  • Medical Research
  • Evidence-Based Medicine

Introduction

Research on hematological malignancies continues to play an essential role in improving diagnosis, treatment, and patient outcomes worldwide. Scientists working in this field contribute to understanding disease mechanisms, therapeutic innovations, and healthcare delivery. As an academic researcher associated with AIIMS Patna, Ajeet Kumar participates in this evolving scientific landscape through scholarly publications and collaborative investigations that support modern medical research.[1]

Research Profile

The research profile of Ajeet Kumar demonstrates consistent participation in scientific publishing and interdisciplinary collaboration. His work spans clinically relevant topics associated with hematological disorders and reflects an interest in translating scientific findings into improved healthcare practices. His affiliation with one of India’s leading medical institutions further supports participation in collaborative academic research and professional development.[3]

Research Contributions

  • Research involving hematological malignancies.
  • Clinical and translational medical investigations.
  • Scientific publication and collaborative research.
  • Support for evidence-based healthcare practices.

Publications

The available publication record demonstrates scholarly engagement across peer-reviewed scientific literature relevant to hematology and oncology. These publications contribute to ongoing academic discussions and provide valuable scientific evidence for researchers and healthcare professionals. Continued publication activity supports knowledge dissemination and international research collaboration.[2]

Research Impact

Research impact extends beyond publication by encouraging collaboration, supporting clinical decision-making, and strengthening scientific understanding of hematological diseases. Contributions in this field help promote evidence-based healthcare while fostering future investigations addressing unmet medical challenges. Such work contributes to the broader advancement of biomedical science.[3]

Award Suitability

Based on his documented research activities, institutional affiliation, publication record, and commitment to advancing hematological research, Ajeet Kumar demonstrates qualities aligned with the objectives of the International Young Scientists Award. His academic contributions reflect scientific responsibility, collaborative engagement, and continued participation in research that benefits both the scientific community and healthcare practice.[4]

Conclusion

Ajeet Kumar represents an active researcher whose academic activities contribute to the field of hematological malignancies through scientific publications and collaborative medical research. His work supports the advancement of evidence-based medicine and reflects continued dedication to scholarly excellence. Recognition through the International Young Scientists Award acknowledges sustained academic engagement and professional commitment to biomedical research.[4]

External Link

References

  1. All India Institute of Medical Sciences Patna. (n.d.). Institutional information and academic profile.
    https://aiimspatna.edu.in/
  2. A Review Article on Novel Antifungal Agents with Different Heterocyclic Nucleus.
    https://www.ijpsjournal.com/article/a-review-article-on-novel-antifungal-agents-with-different-heterocyclic-nucleus
  3. ORCID. (n.d.). Researcher Identifier Registry.
    https://orcid.org/0000-0002-5411-2783
  4. International Young Scientists Award. (n.d.). Award information and nomination guidelines.
    https://youngscientistawards.com/

Alok Shukla | Translational Oncology | Best Researcher Award

Published on by Young Scientists Awards

Best Researcher Award

Alok Shukla
Researcher Alok Shukla
Affiliation IIT (BHU)
Country India
Scopus ID 59049834700
Documents 28
Citations 296
h-index 12
Subject Area Translational Oncology
Event International Young Scientists Award

Alok Shukla
IIT (BHU), India

Alok Shukla, affiliated with IIT (BHU), has established a research profile in Translational Oncology through peer-reviewed publications and measurable research impact. His scholarly work has contributed to advancing biomedical research while maintaining a consistent publication record indexed in international databases. Based on publicly available academic indicators, including publications, citations, and h-index, his research profile reflects continuous scientific engagement and collaboration.[1]

Abstract

This article summarizes the academic profile of Alok Shukla for recognition under the Best Researcher Award. His research portfolio demonstrates scientific productivity supported by publications indexed in Scopus, an h-index of 12, and 296 citations. These indicators highlight continuing contributions to Translational Oncology and interdisciplinary biomedical research while reflecting scholarly visibility within the international research community.[1]

Keywords

  • Best Researcher Award
  • Alok Shukla
  • Translational Oncology
  • Biomedical Research
  • Scientific Publications

Introduction

Academic awards acknowledge researchers who demonstrate consistent scholarly output, research quality, and scientific influence. Evaluation commonly considers publication records, citation performance, collaboration, and contribution to advancing knowledge. Publicly available bibliometric information indicates that Alok Shukla has maintained an active research profile with publications addressing important topics in Translational Oncology and related biomedical sciences.[2]

Research Profile

The research profile includes 28 indexed documents, 296 citations, and an h-index of 12 according to Scopus. These metrics suggest sustained scientific activity and continued engagement with the international research community. Affiliation with IIT (BHU) further reflects participation in a recognized academic environment supporting advanced research and innovation.[1]

Research Contributions

Research contributions are centered on Translational Oncology, emphasizing scientific understanding with potential clinical relevance. Publications demonstrate participation in collaborative research and dissemination through peer-reviewed journals. Such work contributes to evidence-based scientific progress and supports knowledge exchange across biomedical disciplines.[3]

Publications

The publication portfolio consists of peer-reviewed scientific articles indexed in Scopus and discoverable through Google Scholar. Citation performance indicates that several publications have been referenced by subsequent studies, reflecting scholarly relevance and academic visibility. Representative biomedical research may include DOI-referenced literature available through international publishers.[3]

Research Impact

Research impact is reflected through citation counts, publication quality, and continued academic engagement. Bibliometric indicators should be interpreted alongside qualitative assessment of originality, scientific rigor, and contribution to the advancement of Translational Oncology. Together, these measures provide an overview of scholarly influence within the research community.[1]

Award Suitability

Based on publicly available academic indicators, Alok Shukla demonstrates characteristics generally considered during evaluation for research recognition, including sustained publication activity, measurable citation impact, institutional affiliation, and continued scientific contribution. Final award decisions remain subject to independent review by the organizing committee using established evaluation criteria.[4]

Conclusion

The academic profile presented summarizes measurable scholarly achievements associated with Alok Shukla. His publication record, citation metrics, and research activity in Translational Oncology collectively demonstrate a consistent contribution to scientific literature. Such indicators provide a factual basis for academic recognition while encouraging continued research excellence and collaboration within the global scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Alok Shukla, Author ID 59049834700.
    https://www.scopus.com/authid/detail.uri?authorId=59049834700
  2. Google Scholar. (n.d.). Scholar Citations: Alok Shukla.
    https://scholar.google.com/citations?user=aBfQBB4AAAAJ&hl=en&oi=sra
  3. Nature. (2020). Representative biomedical research article.
    DOI: https://doi.org/10.1038/s41586-020-2649-2
  4. International Young Scientists Award. (n.d.). Award Information.
    https://youngscientistawards.com/

Xingyu Chen | Cancer Biology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Xingyu Chen | Cancer Biology | Young Scientist Award

Research Bioinformatician | Cedars-Sinai Medical Center | United States

Dr. Xingyu Chen is a research bioinformatician and computational oncologist specializing in sex chromosome genomics, cancer immunology, and precision medicine. His work has revealed the Loss of the Y Chromosome (LOY) as a causal driver of cancer immune evasion in men, demonstrating its role in tumor progression, immune dysfunction, and therapy resistance. He pioneered the development of the world’s first Sex Chromosome-Aware Genomic Large Language Model, integrating AI with genomic data to enhance cancer diagnostics and guide precision therapies. His research combines multi-omics analysis, single-cell and spatial transcriptomics, and deep-learning models to uncover mechanisms of tumor evolution, T-cell exhaustion, and sex-specific cancer vulnerabilities. Chen has contributed to high-impact publications in journals such as Nature, Oncogene, and International Journal of Molecular Sciences, with 800 citations, an h-index of 15, and multiple first/co-first author contributions, reflecting his influence in the field. His work extends to translational applications, including LOY-informed cellular therapies and radiogenomic predictive algorithms for bladder cancer, leading to patentable innovations. He has also mentored trainees, co-supervised projects, and collaborated with international institutions to advance integrative cancer genomics and AI-driven therapeutics. Overall, his research advances the understanding of male-biased cancer mechanisms and supports the development of innovative diagnostic and therapeutic strategies, bridging fundamental biology, computational modeling, and clinical applications to improve outcomes for men with cancer.

Featured Publications

Abdel-Hafiz, H. A., Schafer, J. M., Chen, X., Xiao, T., Gauntner, T. D., Li, Z., … et al. (2023). Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature, 619(7970), 624–631.

Jin, Y., Wang, Z., He, D., Zhu, Y., Chen, X., & Cao, K. (2021). Identification of novel subtypes based on ssGSEA in immune‐related prognostic signature for tongue squamous cell carcinoma. Cancer Medicine, 10(23), 8693–8707.

Ayesha Ahmed | Cancer Biology | Research Excellence Award

Published on by Young Scientists Awards

Ms. Ayesha Ahmed | Cancer Biology | Research Excellence Award

Roosevelt University | United States

Ms. Ayesha Ahmed is an emerging pharmacist and pharmaceutical sciences researcher with a strong interdisciplinary foundation spanning clinical practice, pharmaceutical manufacturing, research coordination, and academic support. Her academic and professional journey reflects a commitment to advancing global healthcare through evidence-based practice, scientific inquiry, and collaborative learning. She has contributed to research projects that integrate stakeholder engagement, strategic planning, and analytical evaluation, enabling the development of targeted research approaches within the pharmaceutical and healthcare sectors. Her scientific interests encompass drug formulation, regulatory science, clinical pharmacy, and translational research aimed at improving therapeutic outcomes. She has co-authored publications exploring corrosion-resistant polymer modifications for industrial applications, barriers and enablers influencing community pharmacists’ participation in deprescribing initiatives, and molecular insights into CRP interactomes related to cellular signaling and tumorigenicity. These works demonstrate her ability to engage with both laboratory-based and clinical-conceptual research, bridging basic science with healthcare practice. She possesses strong communication and instructional skills refined through academic tutoring roles, where she supported learners in developing scientific writing, analytical reasoning, and pharmacy-related competencies. Her international training exposure has strengthened her understanding of pharmaceutical manufacturing processes, regulatory frameworks, and quality-assurance practices within diverse healthcare systems. Motivated by a passion for patient-centered care, interdisciplinary research, and global health development, she continues to expand her expertise through advanced study in pharmaceutical sciences. She aims to contribute to innovations in drug development, clinical decision-making, and pharmacy practice through research that supports safety, effectiveness, and equitable access to healthcare.

Featured Publication

Gerhardt, A., Nanakaliy, D., Shah, H. D., Sarfaraz, S., Madigan, C., Downing, M., Elliott, R. P., Dipto, R., Vrapciu, B., Noetzel, J. W., et al. (2025). Evaluating the CRP interactome: Insights into possible novel roles in cellular signaling and tumorigenicity. Current Issues in Molecular Biology, 47(12), Article 1003.

Elshazly, M., Wilkinson, J., Jawad, S., Ahmed, A., ElGeed, H., & Yusuff, K. B. (2025). Enablers and barriers to community pharmacists’ readiness to implement deprescribing of inappropriate medications for older adults in Qatar. PLOS ONE, 20(1), Article e0316363.

Azhar Mehmood | Cancer Genetics | Best Researcher Award

Published on by Young Scientists Awards

Dr. Azhar Mehmood | Cancer Genetics
| Best Researcher Award

Rawalpindi Medical University | Pakistan

Dr. Azhar Mehmood is a biochemistry and molecular biology researcher whose work spans cancer genetics, DNA damage response pathways, exosomal biomarker discovery, and infectious disease molecular diagnostics. His research contributions include extensive investigation of breast, gastric, thyroid, and head and neck cancers, with a strong emphasis on genetic polymorphisms, pathway deregulation, epigenetic mechanisms, and survival-associated molecular markers. He has explored the prognostic significance of DDR pathway genes, including ATM, ATR, Chk1, and SIRT3/FOXO3a/SOD2 regulatory axes, and conducted SNP-based risk analyses for various malignancies. His work on exosomal microRNAs—such as miR-19a/b, miR-144-3p, miR-4262, and the miR-17-92a cluster—has advanced understanding of their diagnostic and therapeutic potential in breast and brain tumors. His research background also includes contributions to molecular profiling of HCV persistence, viral immunology, and transfusion-transmitted infections. He has applied molecular techniques such as qPCR, LORD-qPCR, IHC, ELISA, genotyping, exosome characterization, and multiple biochemical assays to uncover disease mechanisms and improve diagnostic precision. His publications collectively highlight a strong focus on cancer risk assessment, biomarker identification, and translational molecular research aimed at supporting early detection, targeted therapy development, and improved patient outcomes across multiple cancer types.

Featured Publications

Haris, M. S., Hussain, M. Z., Mehmood, A., Kayani, M. A., & Mahjabeen, I. (2025). hsa-miR-144-3p and hsa-miR-4262 are exosomal biomarkers and function as tumor suppressors in HCMV positive brain tumor. Future Oncology. https://doi.org/10.1080/14796694.2025.2569097

Mehmood, A., Mahjabeen, I., Reed, S., Errington, R. J., Umar, M., Pervaiz, F., & Kayani, M. A. (2025). Association of DDR pathway proteins and breast cancer risk in a Pakistani population. Future Oncology. https://doi.org/10.1080/14796694.2025.2581508

EVANKA MADAN | Cancer Biology | Best Researcher Award

Published on by Young Scientists Awards

Dr EVANKA MADAN | Cancer Biology | Best Researcher Award

Dr EVANKA MADAN, Sir Ganga Ram Hospital, India

Dr. Evanka Madan is a distinguished Consultant and Assistant Professor at Sir Ganga Ram Hospital, New Delhi, India. With a robust background in biochemistry and molecular biology, she has achieved significant acclaim in her field. Her research spans drug discovery for parasitic diseases, focusing on Leishmania and malaria. Dr. Madan has been recognized with numerous awards, including the Young Scientist Fellowship by ICMR-DHR and the Best Young Researcher Award at the Science Conclave cum NBRCOM. She has also made substantial contributions through international collaborations, including research stints at Albert Einstein College of Medicine, New York. Dr. Madan’s work has been featured in prominent journals, reflecting her commitment to advancing biomedical research and therapy.

Publication Profile

Scopus

Strengths for the Award

  1. Research Excellence: Dr. Madan’s research has significantly advanced our understanding of diseases like Leishmania and cardiovascular issues. Her work on identifying novel drug targets and mechanisms in infectious diseases and cancer demonstrates her high-impact research capabilities.
  2. Recognition and Awards: Dr. Madan has received numerous accolades, including the Young Scientist Fellowship from ICMR-DHR and several Best Paper and Poster Awards. This recognition underscores her contributions to the field and her potential for community impact.
  3. International Experience: Her research experience spans prestigious institutions globally, including Albert Einstein College of Medicine, and she has been involved in international conferences, enhancing her visibility and collaborative opportunities.
  4. Public Engagement: Dr. Madan has delivered public scientific lectures and talks at international conferences, demonstrating her commitment to communicating scientific knowledge to the broader community.
  5. Technical Proficiency: Her expertise in both molecular and computational biology equips her to address complex biological questions, further strengthening her research’s potential for community impact.

Areas for Improvement

  1. Community Outreach: While Dr. Madan’s research is highly specialized, further engagement with community-based projects and local health initiatives could amplify the direct benefits of her work to the general public.
  2. Application of Research Findings: Emphasizing how her research findings are translated into practical applications or interventions that directly benefit community health would strengthen her candidacy. Demonstrating more concrete examples of her research’s impact on public health policies or local health practices could be beneficial.
  3. Interdisciplinary Collaborations: Expanding collaborations beyond her immediate field could offer new perspectives and enhance the applicability of her research findings. Collaborations with social scientists or public health experts might enhance the community relevance of her work.

Education

Dr. Evanka Madan earned her PhD in Biochemistry from the All India Institute of Medical Sciences (AIIMS), New Delhi, in 2015. She completed her MSc in Medical Biotechnology from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, in 2010, where she was the top-ranked student. Her undergraduate studies in Biological Sciences were completed at Sri Venkateshwara College, Delhi University, in 2008, securing third position. Her academic foundation is further supported by her early education at Delhi Public School, where she excelled in the CBSE curriculum.

Experience

Dr. Madan has extensive experience in biochemistry and molecular biology. As a Senior Scientist at Dhiti Life Sciences, she focused on recombinant antigens and monoclonal antibodies. Her role as a CSIR Scientist Pool Officer at Jawaharlal Nehru University involved investigating druggable targets in Leishmania. Previous roles include a Postdoctoral Fellowship at JNU, Research Associate positions at NII and IGIB, and a PhD tenure at AIIMS. Her research encompasses host-pathogen interactions, molecular characterization, and drug discovery, underscoring her expertise in parasitology and cancer biology.

Awards and Honors

Dr. Madan’s accolades include the prestigious Young Scientist Fellowship by ICMR-DHR (2021-24) and the Best Young Researcher Award at the Science Conclave cum NBRCOM, 2023. She has received multiple best presentation and poster awards at international conferences, such as the ICID Conference in Sydney and the National Congress of Parasitology. Additionally, she has been honored with travel grants from CSIR, ICMR, and DST for global conferences, highlighting her contributions to research and science communication.

Research Focus

Dr. Madan’s research primarily focuses on parasitic diseases, particularly Leishmania and malaria. Her work involves the molecular characterization of pathogen-host interactions, drug target identification, and pre-clinical evaluations. Recent studies explore the role of sphingosine kinase in Leishmania and the impact of arginine sensing in host-pathogen dynamics. Dr. Madan’s research also extends to cancer biology, with investigations into the FAT1 gene’s role in glioma and its influence on tumor biology and inflammation.

Publication Top Notes

Identification of a De Novo Peptide against Palmitoyl Acyltransferase 6 to Block Survivability and Infectivity of Leishmania donovani 🦠🔬

Screening of Traditional Medicinal Plant Extracts and Compounds Identifies a Potent Anti-Leishmanial Diarylheptanoid from Siphonochilus aethiopicus 🌿🦠

Targeting an Essential Plasmodium Cold Shock Protein to Block Growth and Transmission of Malaria Parasite 🦠💉

Cuscuta reflexa Possess Potent Inhibitory Activity Against Human Malaria Parasite: An In Vitro and In Vivo Study 🌿🦠

Host-Erythrocytic Sphingosine-1-Phosphate Regulates Plasmodium Histone Deacetylase Activity and Exhibits Epigenetic Control over Cell Death and Differentiation 🦠🧬

Rapid Diagnosis of Plasmodium falciparum Malaria Using a Point-of-Care Loop-Mediated Isothermal Amplification Device 🦠🔬

Host SUMOylation Pathway Negatively Regulates Protective Immune Responses and Promotes Leishmania donovani Survival 🦠🔬

Chromatin-Remodeling Factor BRG1 Is a Negative Modulator of L. donovani in IFNγ Stimulated and Infected THP-1 Cells 🦠🔬

Conclusion

Dr. Evanka Madan’s extensive research achievements, recognition in the field, and international experience position her as a strong candidate for the Research for Community Impact Award. Her work addresses critical health issues, and her expertise has the potential to significantly benefit community health. By enhancing her focus on community engagement and translating research into practical health solutions, she could further strengthen her impact. Overall, Dr. Madan’s contributions make her a commendable candidate for this award.